Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 9.54% and Operating profit at 1.26% over the last 5 years
Flat results in Sep 25
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 1,081 Cr (Small Cap)
15.00
28
1.55%
-0.11
4.07%
0.62
Total Returns (Price + Dividend) 
Latest dividend: 13.75 per share ex-dividend date: Aug-14-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Closure of Trading Window
27-Mar-2026 | Source : BSEWe hereby inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Code read with applicable provisions of SEBI (Prevention of Insider Trading Regulations) 2015 the trading window for dealing in the equity shares of the Company by designated persons of the Company and their immediate relatives as defined in the Code shall remain closed from 01st April 2026 till 48 hours from the declarations of financial results for the quarter and year ended 31st March 2026. The trading window will however be open for general investors.
Announcement under Regulation 30 (LODR)-Change in Directorate
24-Mar-2026 | Source : BSEPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that Mr. Dinesh Bhagat - Nominee Director (DIN - 08354195) has tendered his resignation vide letter dated 23rd March 2026 citing cessation of his term.
The Company Wish To Inform You That Application Has Been Made To BSE For Reclassification Of Status Of Promoter To Public
24-Feb-2026 | Source : BSEDisclosure under Regulation 31 A (8) of SEBI (LODR) Regulations 2015
Corporate Actions 
No Upcoming Board Meetings
Excel Industries Ltd has declared 275% dividend, ex-date: 14 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 4 Schemes (0.01%)
Held by 44 FIIs (2.01%)
Anshul Specialty Molecules Private Limited (42.92%)
Life Insurance Corporation Of India (6.69%)
30.92%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -13.58% vs -12.69% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -60.17% vs -37.23% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.60% vs 29.46% in Sep 2024
Growth in half year ended Sep 2025 is -17.62% vs 770.76% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 11.37% vs 23.22% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -13.05% vs 605.03% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 18.39% vs -24.19% in Mar 2024
YoY Growth in year ended Mar 2025 is 401.53% vs -78.72% in Mar 2024